![Kinneret Livnat Savitsky](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kinneret Livnat Savitsky
Director/Board Member at Biomica Ltd.
Kinneret Livnat Savitsky active positions
Companies | Position | Start | End |
---|---|---|---|
Biomica Ltd.
![]() Biomica Ltd. Miscellaneous Commercial ServicesCommercial Services Biomica Ltd. engages in the provision of biopharmaceutical services. Its technology focuses on the development of therapies for antibiotic resistant bacteria, immuno-oncology, and microbiome-related gastrointestinal (GI) disorders. The company was founded by Yehuda Ringel in 2017 and is headquartered in Rehovot, Israel. | Director/Board Member | - | - |
Career history of Kinneret Livnat Savitsky
Former positions of Kinneret Livnat Savitsky
Companies | Position | Start | End |
---|---|---|---|
MabTrix Ltd.
![]() MabTrix Ltd. Pharmaceuticals: MajorHealth Technology MabTrix Ltd. develops biopharmaceutical products. It develops innovative function-blocking therapeutic monoclonal antibody for inflammatory bowel disease. The company was founded in December 2015 and is headquartered in Ness Ziona, Israel. | Director/Board Member | 2018-05-09 | - |
Statistics
International
Israel | 3 |
Operational
Director/Board Member | 2 |
Sectoral
Commercial Services | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Biomica Ltd.
![]() Biomica Ltd. Miscellaneous Commercial ServicesCommercial Services Biomica Ltd. engages in the provision of biopharmaceutical services. Its technology focuses on the development of therapies for antibiotic resistant bacteria, immuno-oncology, and microbiome-related gastrointestinal (GI) disorders. The company was founded by Yehuda Ringel in 2017 and is headquartered in Rehovot, Israel. | Commercial Services |
MabTrix Ltd.
![]() MabTrix Ltd. Pharmaceuticals: MajorHealth Technology MabTrix Ltd. develops biopharmaceutical products. It develops innovative function-blocking therapeutic monoclonal antibody for inflammatory bowel disease. The company was founded in December 2015 and is headquartered in Ness Ziona, Israel. | Health Technology |